Here are what the editors at HealthDay consider to be the most important developments in Urology for August 2009. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Quality of Care Unchanged Under New Payment System
FRIDAY, Aug. 28 (HealthDay News) -- The implementation of a fixed-price, payment-by-results system for hospitals in the United Kingdom, beginning in 2002, has reduced the length of hospital stays and increased day case (outpatient) admissions, but has had no measurable effect on quality of care, according to a study published Aug. 27 in BMJ.
Abstract
Full Text
Editorial (subscription or payment may be required)
Human Papillomavirus May Be Linked to Penile Cancer
THURSDAY, Aug. 27 (HealthDay News) -- Human papillomavirus (HPV) infection, especially with HPV 16-18, may be associated with nearly half of the cases of penile carcinoma, according to a study published online Aug. 25 in the Journal of Clinical Pathology.
Abstract
Full Text (subscription or payment may be required)
Hormones Hike Death Risk in Some Prostate Cancers
TUESDAY, Aug. 25 (HealthDay News) -- Men with prostate cancer who receive neoadjuvant hormone therapy in combination with radiotherapy face an increased all-cause mortality risk if they have significant cardiovascular comorbidities, including congestive heart failure or prior myocardial infarction, according to a study reported in the Aug. 26 issue of the Journal of the American Medical Association.
Abstract
Full Text (subscription or payment may be required)
Department Issues New HIPAA Notification Regulations
TUESDAY, Aug. 25 (HealthDay News) -- The U.S. Department of Health and Human Services issued new regulations on Aug. 19 requiring entities covered by the Health Insurance Portability and Accountability Act (HIPAA) to notify individuals after their health information has been breached.
Adjuvant Chemotherapy Little Help for Urothelial Cancer
FRIDAY, Aug. 21 (HealthDay News) -- Patients treated surgically for upper tract urothelial carcinoma are not usually offered adjuvant chemotherapy, and for those who are, the treatment does not seem to have much impact on the odds of survival, according to a study published in the September issue of the Journal of Urology.
Gatorade Not Found to Affect Risk of Urinary Stones
THURSDAY, Aug. 20 (HealthDay News) -- Although consumption of the carbohydrate-electrolyte drink Gatorade increases mean urinary sodium and chloride levels, the increase is within normal parameters and has no clinical significance, according to a study published in the September issue of the Journal of Urology.
Alarm Symptoms Often Do Not Result in Timely Diagnosis
FRIDAY, Aug. 14 (HealthDay News) -- Many patients who present with certain alarm symptoms, including hematuria and rectal bleeding, do not receive a diagnosis in a reasonable amount of time, according to a study published online Aug. 13 in BMJ.
High Urinary Albumin Affects Death Risk for Heart Failure
FRIDAY, Aug. 14 (HealthDay News) -- An elevated urinary albumin to creatinine ratio (UACR) is a predictor of cardiovascular events and death in heart failure patients and may offer clinicians a prognostic guide for risk stratification, according to a study reported in the Aug. 15 issue of The Lancet.
Abstract
Full Text (subscription or payment may be required)
Combination Therapy Benefits Urinary Tract Symptoms
THURSDAY, Aug. 13 (HealthDay News) -- The use of the cyclooxygenase (COX)-2 inhibitor tenoxicam may provide greater benefits for lower urinary tract symptoms due to benign prostatic hyperplasia when added to the alpha blocker doxazosin, according to research published in the August issue of Urology.
Abstract
Full Text (subscription or payment may be required)
Clodronate Improves Survival in Advanced Prostate Cancer
THURSDAY, Aug. 13 (HealthDay News) -- Sodium clodronate improves overall survival in men with metastatic prostate cancer, but it does not reduce the risk of death in men with non-metastatic prostate cancer, according to a study published online Aug. 11 in The Lancet Oncology.
Abstract
Full Text (subscription or payment may be required)
Poor Bladder Management Linked to Low Quality of Life
THURSDAY, Aug. 13 (HealthDay News) -- Bladder treatment that leads to favorable urodynamic results is linked to better quality of life in urinary tract dysfunction patients with spinal cord lesions, according to a study published in the August issue of Urology.
Abstract
Full Text (subscription or payment may be required)
FDA Aims to Ease Access to Investigational Drugs
WEDNESDAY, Aug. 12 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has published two new rules to help seriously ill patients gain access to investigational drugs and biologics, according to an Aug. 12 release issued by the agency.
More Information
Access to Investigational Drugs
Incontinence Treatment Trends Changed in the 1990s
TUESDAY, Aug. 11 (HealthDay News) -- Trends in the surgical management of stress urinary incontinence among women in the United States changed rapidly from 1992 to 2001, according to a study in the August issue of Urology.
Abstract
Full Text (subscription or payment may be required)
Denosumab Linked to Lower Fracture Risk in Two Groups
TUESDAY, Aug. 11 (HealthDay News) -- Denosumab is linked to a reduction in fractures in women with osteoporosis and in men undergoing androgen-deprivation therapy for non-metastatic prostate cancer, according to two studies published online Aug. 11 in the New England Journal of Medicine.
Abstract - Cummings
Full Text
Abstract - Smith
Full Text
Editorial
More Research Links Alcohol Intake to Cancer Risk
MONDAY, Aug. 10 (HealthDay News) -- Men who drink moderate or high amounts of alcohol over their lifetime may face a higher risk of several types of cancer, according to research published in the current issue of Cancer Detection and Prevention.
Abstract
Full Text (subscription or payment may be required)
HHS Releases Reports on Health Insurance Reform
FRIDAY, Aug. 7 (HealthDay News) -- The U.S. Department of Health and Human Services (HHS) has released a series of state-by-state reports that outline its conclusions on the effects health insurance reform would have on health care for Americans, according to an Aug. 7 release issued by the agency.
3D Prostate Mapping Biopsy Shows Staging Accuracy
THURSDAY, Aug. 6 (HealthDay News) -- Three-dimensional prostate mapping biopsy (3D-PMB) may provide better accuracy in staging prostate cancer, which could have a major effect on patients' outcomes, according to research published online Aug. 3 in the Journal of Clinical Oncology.
Abstract
Full Text (subscription or payment may be required)
Follow-Up Tests Often Not Done in Testicular Cancer
WEDNESDAY, Aug. 5 (HealthDay News) -- Although many men with early stage testicular cancer are managed by surveillance, many do not receive the recommended follow-up testing, according to a study published online Aug. 3 in the Journal of Clinical Oncology.
Abstract
Full Text (subscription or payment may be required)
Neonatal Urinary Tract Infection Prognosis Difficult
MONDAY, Aug. 3 (HealthDay News) -- Renal scintigraphy of young infants with urinary tract infections (UTIs) can help rule out permanent renal damage, but catheterization to perform voiding cystourethrography may still be required to detect congenital defects such as dilating vesicoureteral reflux, according to a study published online Aug. 3 in Pediatrics.
Abstract
Full Text (subscription or payment may be required)
Gene Variant Linked to Urinary Bladder Cancer
MONDAY, Aug. 3 (HealthDay News) -- A variant of a gene initially identified through its overexpression in prostate cancers is also associated with bladder cancers, according to a study published online Aug. 2 in Nature Genetics.
Abstract
Full Text (subscription or payment may be required)
Copyright © 2009 ScoutNews, LLC. All rights reserved.
| Previous: August 2009 Briefing - Surgery | Next: August 2009 Briefing - Internal Medicine |
|
Reader comments on this article are listed below. Review our comments policy. |
Submit your opinion:
 |
||
|
|
Are you a Doctor, Pharmacist, PA or a Nurse?Join the Doctors Lounge online medical community
|
|
